Clinical Trials Logo

Clinical Trial Summary

Our aim is to assess the role of the gray scale and color Doppler ultrasound in diagnosis of the different pediatric neck masses .

Clinical Trial Description

Neck masses are a common occurrence in the pediatric population and often represent a diagnostic challenge for the clinician involved . fortunately , the vast majority of these lesions are ultimately proven to be benign in nature (1). Even though clinical examination and patient's history are the first and indispensable steps in the initial diagnosis, the role of imaging is crucial, not only to determine whether a mass represents a true tumour or not , but also to achieve a more correct diagnosis and determine the extension of the lesion and its relation with the nearby anatomic structures (2). Ultrasound (US) should serve as the primary initial imaging modality in children for palpable masses and assessment of superficial glandular structures. Because of the smaller neck size and less subcutaneous fat, sonographic penetration and resolution is generally improved as compared with adults (3 ). Doppler imaging can also elucidate how flow is distributed within a mass may have diagnostic significance and help us in determining the nature of the lesion as well as it is of great importance in assessment of vascular lesions (4) Though ultrasound is most common method used for evaluation of pediatric neck masses , and CT as well as MRI are used as an additional tool when necessary ( 3 ) , few studies have looked at the sensitivity and specificity of the different imaging modalities of the pediatric neck masses and most studies have investigated the epidemiology of the pediatric neck masses (5) which make histopathological diagnosis still the gold standard in distinguishing the etiology of pediatric neck masses and ruling out malignant disease (6) ;

Study Design

Related Conditions & MeSH terms

NCT number NCT04856020
Study type Observational
Source Assiut University
Contact Monica Sobhy
Phone +2001278489110
Email [email protected]
Status Not yet recruiting
Start date April 2021
Completion date May 2023

See also
  Status Clinical Trial Phase
Not yet recruiting NCT03728543 - the Efficacy and Safety of Sugammadex in Children 0-2 Years Old Phase 2/Phase 3
Recruiting NCT04471961 - Analyse of Tumour and Constitutional DNA for the Study of the Determinism in Child Neoplasia N/A